Thrina Loennechen

2.1k total citations · 1 hit paper
35 papers, 1.7k citations indexed

About

Thrina Loennechen is a scholar working on Molecular Biology, Cancer Research and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Thrina Loennechen has authored 35 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Thrina Loennechen's work include Protease and Inhibitor Mechanisms (9 papers), Acute Lymphoblastic Leukemia research (8 papers) and S100 Proteins and Annexins (6 papers). Thrina Loennechen is often cited by papers focused on Protease and Inhibitor Mechanisms (9 papers), Acute Lymphoblastic Leukemia research (8 papers) and S100 Proteins and Annexins (6 papers). Thrina Loennechen collaborates with scholars based in Norway, United States and United Kingdom. Thrina Loennechen's co-authors include Charles R. Yates, Eugene Y. Krynetski, Michael Y. Fessing, Hung-Liang Tai, Mary V. Relling, William E. Evans, William E. Evans, Ching‐Hon Pui, Natalia F. Krynetskaia and Jarle Aarbakke and has published in prestigious journals such as Annals of Internal Medicine, American Journal Of Pathology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Thrina Loennechen

34 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance

1997 583 citations Charles R. Yates, Eugene Y. Krynetski et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thrina Loennechen Norway	17	886	619	521	285	230	35	1.7k
Hung-Liang Tai United States	9	861 1.0×	477 0.8×	489 0.9×	234 0.8×	226 1.0×	10	1.5k
Tracy Lightfoot United Kingdom	24	727 0.8×	696 1.1×	528 1.0×	564 2.0×	51 0.2×	44	2.1k
Evans We United States	30	1.1k 1.3×	795 1.3×	685 1.3×	614 2.2×	99 0.4×	66	2.7k
Laimonas Griškevičius Lithuania	26	719 0.8×	448 0.7×	512 1.0×	706 2.5×	116 0.5×	110	2.6k
MV Relling United States	12	884 1.0×	329 0.5×	725 1.4×	226 0.8×	101 0.4×	14	1.5k
H. L. McLeod United States	21	307 0.3×	677 1.1×	340 0.7×	1.1k 3.7×	65 0.3×	60	1.8k
Stefan Söderhäll Sweden	26	819 0.9×	851 1.4×	514 1.0×	435 1.5×	100 0.4×	69	2.1k
John Lilleyman United Kingdom	17	593 0.7×	204 0.3×	351 0.7×	123 0.4×	92 0.4×	31	1.0k
Christine Hartford United States	22	459 0.5×	574 0.9×	298 0.6×	339 1.2×	25 0.1×	36	1.7k
Torben Stamm Mikkelsen Denmark	13	336 0.4×	251 0.4×	343 0.7×	388 1.4×	22 0.1×	37	1.1k

Countries citing papers authored by Thrina Loennechen

Since Specialization

Citations

This map shows the geographic impact of Thrina Loennechen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thrina Loennechen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thrina Loennechen more than expected).

Fields of papers citing papers by Thrina Loennechen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thrina Loennechen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thrina Loennechen. The network helps show where Thrina Loennechen may publish in the future.

Co-authorship network of co-authors of Thrina Loennechen

This figure shows the co-authorship network connecting the top 25 collaborators of Thrina Loennechen. A scholar is included among the top collaborators of Thrina Loennechen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thrina Loennechen. Thrina Loennechen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hadler‐Olsen, Elin, Oddveig Rikardsen, Sonja E. Steigen, et al.. (2011). S100A4 Expression in Xenograft Tumors of Human Carcinoma Cell Lines Is Induced by the Tumor Microenvironment. American Journal Of Pathology. 178(5). 2389–2396. 6 indexed citations

Hudson, Steve, et al.. (2009). Adherence to Medication Guideline Criteria in Cancer Pain Management. Journal of Pain and Symptom Management. 37(6). 1006–1018. 26 indexed citations

Johansen, Harald Thidemann, et al.. (2009). Collagen I regulates matrix metalloproteinase‐2 activation in osteosarcoma cells independent of S100A4. FEBS Journal. 276(18). 5275–5286. 23 indexed citations

Loennechen, Thrina, et al.. (2008). Dysregulation of Matrix Metalloproteinases and their Tissue Inhibitors by S100A4. Connective Tissue Research. 49(3-4). 185–188. 17 indexed citations

Hudson, Steve, et al.. (2006). Design and validation of a medication assessment tool for cancer pain management. Pharmacy World & Science. 28(6). 342–351. 18 indexed citations

Mathisen, Berit, Thrina Loennechen, Tobias Gedde‐Dahl, & Jan‐Olof Winberg. (2005). Fibroblast heterogeneity in collagenolytic response to colchicine. Biochemical Pharmacology. 71(5). 574–583. 6 indexed citations

Mathisen, Berit, et al.. (2003). S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells. Clinical & Experimental Metastasis. 20(8). 701–711. 63 indexed citations

Loennechen, Thrina, et al.. (2003). Colchicine induces membrane-associated activation of matrix metalloproteinase-2 in osteosarcoma cells in an S100A4-independent manner. Biochemical Pharmacology. 66(12). 2341–2353. 22 indexed citations

Loennechen, Thrina, et al.. (1999). The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX). General Pharmacology The Vascular System. 33(4). 341–346. 35 indexed citations

10.

Seternes, Ole Morten, et al.. (1998). Synergistic increase in c-fos expression by simultaneous activation of the ras/raf/map kinase- and protein kinase A signaling pathways is mediated by the c-fos AP-1 and SRE sites. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1395(3). 345–360. 27 indexed citations

11.

Loennechen, Thrina, et al.. (1998). Increased Concentrations of Methylated 6-Mercaptopurine Metabolites and 6-Thioguanine Nucleotides in Human Leukemic Cells In Vitro by Methotrexate. Biochemical Pharmacology. 55(10). 1641–1646. 14 indexed citations

12.

Bergan, Stein, et al.. (1997). Analysis of Methylated 6-Mercaptopurine Metabolites in Human Blood Cells. Therapeutic Drug Monitoring. 19(6). 663–668. 11 indexed citations

13.

Svendsrud, Debbie Hege, Thrina Loennechen, & Jan‐Olof Winberg. (1997). Effect of adenosine analogues on the expression of matrix metalloproteinases and their inhibitors from human dermal fibroblasts. Biochemical Pharmacology. 53(10). 1511–1520. 11 indexed citations

14.

Loennechen, Thrina, et al.. (1997). Effects of 3‐Deazaadenosine on Apoptosis‐Related Gene Transcripts in HL‐60 Cells. Pharmacology & Toxicology. 81(5). 199–204. 5 indexed citations

15.

Krynetski, Eugene Y., Hung-Liang Tai, Charles R. Yates, et al.. (1996). Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics. 6(4). 279–290. 196 indexed citations

16.

Loennechen, Thrina, Inge W. Nilsen, Ugo Moens, Anders Andersen, & Jarle Aarbakke. (1992). Is there an association between an increase in c-myc RNA steady state levels and c-myc methylation in HL-60 cells treated with 3-deaza-(±)-aristeromycin, an indirect inhibitor of methylation?. Biochemical Pharmacology. 44(7). 1283–1289. 5 indexed citations

17.

Klemetsdal, B., et al.. (1992). Interethnic difference in thiopurine methyltransferase activity. Clinical Pharmacology & Therapeutics. 51(1). 24–31. 61 indexed citations

18.

Loennechen, Thrina, et al.. (1990). High-Performance Liquid Chromatographic Determination of Levomepromazine (Methotrimeprazine) and Its Main Metabolites in Serum and Urine. Therapeutic Drug Monitoring. 12(6). 574–581. 16 indexed citations

19.

Loennechen, Thrina, et al.. (1989). DNA-methylation in HL-60 cells treated with 3-deaza-(±)-aristeromycin and 3-deazaadenosine. Biochemical Pharmacology. 38(16). 2748–2751. 8 indexed citations

20.

Loennechen, Thrina, Arne Jørgen Aasen, Olof Wennerström, et al.. (1979). Synthesis of N-(N-Acetyl-L-aspartyl)-4-aminobutyric Acid (Ac-Asp-gammaAbu).. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 33b. 387–389. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact